4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
FibroBiologics, Inc. (FBLG) operates in the Biotechnology industry and is headquartered in Houston, United States with about 15 employees. Its market capitalization is roughly $4 million. In the fiscal year ended 2025-12-31, FBLG reported $0M in revenue and ($19M) in net income.
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($17M) | ($14M) | ($9M) | ($4M) |
| Net Income | ($19M) | ($11M) | ($16M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($5M) | ($3M) | ($5M) | ($4M) | ($4M) | — |
| Net Income | ($5M) | ($3M) | ($6M) | ($5M) | ($5M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $10M | $16M | $12M | $5M | — |
| Total Liabilities | $4M | $14M | $11M | $9M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FBLG viewer.
About TickerBase · Data methodology & sources